Valuation Mayinglong Pharmaceutical Group Co., LTD.

Stocks

End-of-day quote Shanghai S.E. 11/09/2026			5-day change	1st Jan Change
22.13 ^CNY	-1.64%		-4.03%	-20.96%

08-25	Mayinglong Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026	CI
07-10	China Includes Two Mayinglong Pharmaceutical Products in Essential Medicines List	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2023	2024	2025	2026	2027	2028
Market Cap ¹	10,423	11,255	12,070	9,539	-	-
Change	-	7.98%	7.24%	-20.96%	-	-
Enterprise Value (EV)	10,423	11,255	12,070	9,539	9,539	9,539
Change	-	7.98%	7.24%	-20.96%	0%	0%
P/E	-	21.2x	20.7x	14.3x	12.9x	11.6x
PBR	-	2.77x	2.76x	2.01x	1.74x	1.5x
PEG	-	-	2.12x	1x	1.2x	1.1x
Capitalization / Revenue	3.32x	3.02x	3.12x	2.27x	2.07x	1.92x
EV / Revenue	0x	0x	0x	2.27x	2.07x	1.92x
EV / EBITDA	-	0x	0x	11.4x	10.3x	9.4x
EV / EBIT	-	0x	0x	11.9x	10.8x	9.78x
EV / FCF	-	0x	-	9.63x	9.47x	8.69x
FCF Yield	-	2.62%	-	10.4%	10.6%	11.5%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	-	1.23	1.35	1.545	1.715	1.9
Distribution rate	-	-	-	-	-	-
Net sales ¹	3,137	3,728	3,867	4,198	4,606	4,980
EBITDA ¹	-	686.7	791.2	834	926.5	1,014
EBIT ¹	-	666.8	719.9	801	886.5	975
Net income ¹	443.3	528.1	581.5	667.5	739.5	819
Net Debt	-	-	-	-	-	-
Reference price ²	24.18	26.11	28.00	22.13	22.13	22.13
Nbr of stocks (in thousands)	431,054	431,054	431,054	431,054	-	-
Announcement Date	12/04/24	02/04/25	24/04/26	-	-	-

¹CNY in Million²CNY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
MAYINGLONG PHARMACEUTICAL GROUP CO., LTD.	14.32x	-	-	-	1.42B
ELI LILLY AND COMPANY	31.77x	11.54x	23.41x	0.62%	994B
JOHNSON & JOHNSON	29.54x	-	-	2.02%	640B
ABBVIE INC.	32.92x	7.63x	15.78x	2.67%	454B
ROCHE HOLDING AG	18.71x	4.57x	11.31x	2.91%	337B
NOVARTIS AG	19.41x	5.08x	12.59x	3.21%	261B
ASTRAZENECA PLC	20.34x	4.19x	11.96x	2.11%	246B
AMGEN INC.	23.87x	6.3x	11.23x	2.67%	204B
NOVO NORDISK A/S	12.3x	4.48x	9.37x	4.08%	190B
GILEAD SCIENCES, INC.	-43.47x	6.35x	24.81x	2.29%	178B
Average	15.97x	6.27x	15.06x	2.51%	350.62B
Weighted average by Cap.	23.19x	7.72x	17.10x	2.05%